Sangamo Therapeutics (NASDAQ:SGMO) Cut to “Strong Sell” at Zacks Research

Chronological Source Flow
Back

AI Fusion Summary

Zacks cut Sangamo to strong sell; Weiss and Wall Street Zen sold, HC Wainwright issued a buy with $10 target. Mitek downgraded to hold by Zacks, held by Weiss, upgraded to strong‑buy by Wall Street Zen, raised to buy.
#ZACKS_RESEARCH #SANGAMO_THERAPEUTICS #MITEK_SYSTEMS #STOCK_RATING #INVESTMENT_ANALYSIS
19/04 08:28 defenseworld.net
3 Πηγές

Sangamo Therapeutics (NASDAQ:SGMO) Cut to “Strong Sell” at Zacks Research

POLITICSEARTHQUAKEANALYST ARTICLES - USCOMPANIES
19/04 08:56 defenseworld.net

Mitek Systems (NASDAQ:MITK) Cut to Hold at Zacks Research

COMPANIESPOLITICSANALYST ARTICLES - US
19/04 09:44 defenseworld.net

Archrock (NYSE:AROC) Cut to Hold at Zacks Research

ANALYST ARTICLES - USECONOMYPOLITICSCOMPANIES
Comments
Loading...
0